Die Anfälligkeit für Pseudomonas-Infektionen ist insbesondere bei zystischer Fibrose für die Prognose entscheidend. Genetische Varianten im FCGR2A-Gen sind für die Suszeptibilität chronischer Infektionen bestimmend.
1. |
Eiberg H et al. (1985) Cystic fibrosis; hint of linkage with F13B. |
2. |
De Rose V et al. (2005) Fcgamma receptor IIA genotype and susceptibility to P. aeruginosa infection in patients with cystic fibrosis. |
3. |
Chong JX et al. (2012) A population-based study of autosomal-recessive disease-causing mutations in a founder population. |
4. |
Buranawuti K et al. (2007) Variants in mannose-binding lectin and tumour necrosis factor alpha affect survival in cystic fibrosis. |
5. |
Garred P et al. (1999) Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. |
6. |
Davies J et al. (2000) Differential binding of mannose-binding lectin to respiratory pathogens in cystic fibrosis. |
7. |
Gabolde M et al. (2001) The mannose binding lectin gene influences the severity of chronic liver disease in cystic fibrosis. |
8. |
Yarden J et al. (2004) Polymorphisms in the mannose binding lectin gene affect the cystic fibrosis pulmonary phenotype. |
9. |
Dorfman R et al. (2008) Complex two-gene modulation of lung disease severity in children with cystic fibrosis. |
10. |
Sheridan MB et al. (2005) Mutations in the beta-subunit of the epithelial Na+ channel in patients with a cystic fibrosis-like syndrome. |
11. |
Viel M et al. (2008) ENaCbeta and gamma genes as modifier genes in cystic fibrosis. |
12. |
Fajac I et al. (2008) Could a defective epithelial sodium channel lead to bronchiectasis. |
14. |
Azad AK et al. (2009) Mutations in the amiloride-sensitive epithelial sodium channel in patients with cystic fibrosis-like disease. |
15. |
Mekus F et al. (1998) Cystic-fibrosis-like disease unrelated to the cystic fibrosis transmembrane conductance regulator. |
16. |
Savov A et al. (1995) Double mutant alleles: are they rare? |
17. |
Lazarin GA et al. (2013) An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individuals. |
18. |
Sharer N et al. (1998) Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. |
19. |
Cohn JA et al. (1998) Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. |
20. |
Warner JO et al. (1976) Cystic fibrosis heterozygosity in the pathogenesis of allergy. |
21. |
Hösli P et al. (1979) Detection of cystic fibrosis homozygotes and heterozygotes with plasma. |
22. |
None (1979) Increased resistance to influenza as a possible source of heterozygote advantage in cystic fibrosis. |
23. |
Wilson GB et al. (1975) Studies on cystic fibrosis using isoelectric focusing. I. An assay for detection of cystic fibrosis homozygotes and heterozygote carriers from serum. |
24. |
None (1979) Epidemiology of cystic fibrosis: a review. |
25. |
di Sant'agnese PA et al. (1979) Cystic fibrosis in adults. 75 cases and a review of 232 cases in the literature. |
26. |
Katznelson D et al. (1978) Cystic fibrosis in Israel: clinical and genetic aspects. |
27. |
Stern RC et al. (1978) Intermediate-range sweat chloride concentration and Pseudomonas bronchitis. A cystic fibrosis variant with preservation of exocrine pancreatic function. |
28. |
Danes BS et al. (1978) Cystic fibrosis: cell culture classes in a Danish population. |
29. |
Breslow JL et al. (1978) Enhanced dexamethasone resistance in cystic fibrosis cells: potential use for heterozygote detection and prenatal diagnosis. |
30. |
Bois E et al. (1978) Cluster of cystic fibrosis cases in a limited area of Brittany (France). |
31. |
Di Sant'Agnese PA et al. (1976) Research in cystic fibrosis (first of three parts). |
32. |
Danes BS et al. (1977) Cystic fibrosis: Evidence for a genetic compound from a family study in cell culture. |
33. |
Shwachman H et al. (1977) Cystic fibrosis: a new outlook. 70 patients above 25 years of age. |
34. |
Blanck RR et al. (1976) Fertility in a man with cystic fibrosis. |
35. |
Goodchild MC et al. (1976) A search for linkage in cystic fibrosis. |
36. |
Rao GJ et al. (1975) Deficiency of arginine esterase in cystic fibrosis of the pancreas: demonstration of the proteolytic nature of the activity. |
37. |
Engelhardt JF et al. (1992) In vivo retroviral gene transfer into human bronchial epithelia of xenografts. |
38. |
Cheadle JP et al. (1992) A new missense mutation (R1283M) in exon 20 of the cystic fibrosis transmembrane conductance regulator gene. |
39. |
None (1992) No CFTR: are CF symptoms milder? |
40. |
Férec C et al. (1992) Detection of over 98% cystic fibrosis mutations in a Celtic population. |
41. |
Colledge WH et al. (1992) Cystic fibrosis mouse with intestinal obstruction. |
42. |
Rosenfeld MA et al. (1992) In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. |
43. |
Bradbury NA et al. (1992) Regulation of plasma membrane recycling by CFTR. |
44. |
None (1992) Cystic fibrosis: molecular biology and therapeutic implications. |
45. |
Kristidis P et al. (1992) Genetic determination of exocrine pancreatic function in cystic fibrosis. |
46. |
Cutting GR et al. (1992) Analysis of four diverse population groups indicates that a subset of cystic fibrosis mutations occur in common among Caucasians. |
48. |
Snouwaert JN et al. (1992) An animal model for cystic fibrosis made by gene targeting. |
49. |
Clarke LL et al. (1992) Defective epithelial chloride transport in a gene-targeted mouse model of cystic fibrosis. |
50. |
Handyside AH et al. (1992) Birth of a normal girl after in vitro fertilization and preimplantation diagnostic testing for cystic fibrosis. |
51. |
Dorin JR et al. (1992) Cystic fibrosis in the mouse by targeted insertional mutagenesis. |
52. |
Abeliovich D et al. (1992) Screening for five mutations detects 97% of cystic fibrosis (CF) chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population. |
53. |
Cheadle J et al. (1992) Mild pulmonary disease in a cystic fibrosis child homozygous for R553X. |
54. |
Hubbard RC et al. (1992) A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis. |
55. |
Laroche D et al. (1991) Abnormal frequency of delta F508 mutation in neonatal transitory hypertrypsinaemia. |
56. |
Schoumacher RA et al. (1990) A cystic fibrosis pancreatic adenocarcinoma cell line. |
57. |
Rich DP et al. (1990) Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells. |
58. |
Devoto M et al. (1991) Screening for non-delta F508 mutations in five exons of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in Italy. |
59. |
Marino CR et al. (1991) Localization of the cystic fibrosis transmembrane conductance regulator in pancreas. |
60. |
Dörk T et al. (1991) Cystic fibrosis with three mutations in the cystic fibrosis transmembrane conductance regulator gene. |
61. |
Rodman DM et al. (1991) The cystic fibrosis heterozygote--advantage in surviving cholera? |
62. |
Barreto C et al. (1991) A fertile male with cystic fibrosis: molecular genetic analysis. |
63. |
Hammond KB et al. (1991) Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations. |
64. |
Nunes V et al. (1991) Analysis of 14 cystic fibrosis mutations in five south European populations. |
65. |
Gasparini P et al. (1990) The genotype of a new linked DNA marker, MP6d-9, is related to the clinical course of cystic fibrosis. |
66. |
Dumur V et al. (1990) Abnormal distribution of cystic fibrosis delta F508 allele in adults with chronic bronchial hypersecretion. |
67. |
Ten Kate LP et al. (1991) Consanguinity sans reproche. |
68. |
Curtis A et al. (1991) Association of less common cystic fibrosis mutations with a mild phenotype. |
69. |
None (1990) Gradient of distribution in Europe of the major CF mutation and of its associated haplotype. European Working Group on CF Genetics (EWGCFG). |
70. |
Edwards JH et al. (1990) The slash sheet: a simple procedure for risk analysis in cystic fibrosis. |
71. |
Lemna WK et al. (1990) Mutation analysis for heterozygote detection and the prenatal diagnosis of cystic fibrosis. |
72. |
None (1990) Screening for cystic fibrosis; public policy and personal choices. |
73. |
Bilton D et al. (1990) Pathology of common bile duct stenosis in cystic fibrosis. |
74. |
Ferrari M et al. (1990) Genetic differences in cystic fibrosis patients with and without pancreatic insufficiency. An Italian collaborative study. |
75. |
Klinger K et al. (1990) Cystic fibrosis mutations in the Hutterite Brethren. |
76. |
None () CpG-rich islands and the function of DNA methylation. |
77. |
None (1988) Cystic fibrosis and chloride-secreting diarrhoea. |
78. |
Landry DW et al. (1989) Purification and reconstitution of chloride channels from kidney and trachea. |
79. |
Jetten AM et al. (1989) Persistence of abnormal chloride conductance regulation in transformed cystic fibrosis epithelia. |
80. |
None (1989) The basic defect in cystic fibrosis. |
82. |
Fujiwara TM et al. (1989) Genealogical analysis of cystic fibrosis families and chromosome 7q RFLP haplotypes in the Hutterite Brethren. |
83. |
Mornet E et al. (1989) Genetic heterogeneity between two clinical forms of cystic fibrosis evidenced by familial analysis and linked DNA probes. |
84. |
Kerem BS et al. (1989) DNA marker haplotype association with pancreatic sufficiency in cystic fibrosis. |
85. |
McMillan SA et al. (1989) T cell receptor beta chain polymorphisms are associated with cystic fibrosis. |
86. |
Kerem B et al. (1989) Identification of the cystic fibrosis gene: genetic analysis. |
87. |
Voss R et al. (1989) Isodisomy of chromosome 7 in a patient with cystic fibrosis: could uniparental disomy be common in humans? |
88. |
Hill AJ et al. (1989) Linkage disequilibrium and CF allele segregation analysis in cystic fibrosis families in Northern Ireland. |
89. |
Devoto M et al. (1989) Haplotypes in cystic fibrosis patients with or without pancreatic insufficiency from four European populations. |
90. |
Estivill X et al. (1989) Delta F508 gene deletion in cystic fibrosis in southern Europe. |
91. |
McIntosh I et al. (1989) Frequency of delta F508 mutation on cystic fibrosis chromosomes in UK. |
92. |
Romeo G et al. (1989) Why is the cystic fibrosis gene so frequent? |
93. |
Corey M et al. (1989) Familial concordance of pancreatic function in cystic fibrosis. |
94. |
Nazer H et al. (1989) Cystic fibrosis in Saudi Arabia. |
95. |
Scambler PJ et al. (1985) Linkage of COL1A2 collagen gene to cystic fibrosis, and its clinical implications. |
96. |
Cleghorn GJ et al. (1986) Treatment of distal intestinal obstruction syndrome in cystic fibrosis with a balanced intestinal lavage solution. |
97. |
Farrall M et al. (1986) First-trimester prenatal diagnosis of cystic fibrosis with linked DNA probes. |
98. |
White R et al. (1986) Further linkage data on cystic fibrosis: the Utah Study. |
99. |
Spence JE et al. (1986) Linkage of DNA markers to cystic fibrosis in 26 families. |
100. |
Watkins PC et al. (1986) A linkage study of cystic fibrosis in extended multigenerational pedigrees. |
101. |
Estivill X et al. () A candidate for the cystic fibrosis locus isolated by selection for methylation-free islands. |
102. |
Siraganian PA et al. (1987) Cystic fibrosis and ileal carcinoma. |
103. |
Mornet E et al. (1988) Genetic differences between cystic fibrosis with and without meconium ileus. |
104. |
Spence JE et al. (1988) Uniparental disomy as a mechanism for human genetic disease. |
105. |
Morreau J et al. (1988) Cystic fibrosis: screening for a DNA deletion by field inversion gel electrophoresis. |
106. |
Harris A et al. (1988) Cystic fibrosis typing with DNA probes: experience of a screening laboratory. |
107. |
Shepherd RW et al. (1988) Increased energy expenditure in young children with cystic fibrosis. |
108. |
Estivill X et al. (1988) Linkage disequilibrium between cystic fibrosis and linked DNA polymorphisms in Italian families: a collaborative study. |
109. |
Krawczak M et al. (1988) Allelic association of the cystic fibrosis locus and two DNA markers, XV2c and KM19, in 55 German families. |
110. |
Beaudet AL et al. (1989) Linkage disequilibrium, cystic fibrosis, and genetic counseling. |
111. |
Knowles MR et al. (1989) Mild cystic fibrosis in a consanguineous family. |
112. |
Scambler P et al. (1985) Linkage studies between polymorphic markers on chromosome 4 and cystic fibrosis. |
113. |
Tsui LC et al. (1985) Cystic fibrosis locus defined by a genetically linked polymorphic DNA marker. |
114. |
Eiberg H et al. (1985) Linkage relationships of paraoxonase (PON) with other markers: indication of PON-cystic fibrosis synteny. |
115. |
Knowlton RG et al. () A polymorphic DNA marker linked to cystic fibrosis is located on chromosome 7. |
116. |
Wainwright BJ et al. () Localization of cystic fibrosis locus to human chromosome 7cen-q22. |
117. |
Farrall M et al. (1986) The analysis of multiple polymorphic loci on a single human chromosome to exclude linkage to inherited disease: cystic fibrosis and chromosome 4. |
118. |
Buchwald M et al. (1986) Linkage of cystic fibrosis to the pro alpha 2(I) collagen gene, COL1A2, on chromosome 7. |
119. |
Brown WR et al. () Long-range restriction site mapping of mammalian genomic DNA. |
120. |
Farrall M et al. (1986) Cystic fibrosis carrier detection using a linked gene probe. |
121. |
Beaudet A et al. (1986) Linkage of cystic fibrosis to two tightly linked DNA markers: joint report from a collaborative study. |
122. |
Bowcock AM et al. (1986) Genetic analysis of cystic fibrosis: linkage of DNA and classical markers in multiplex families. |
123. |
Naylor SL et al. (1986) Linkage of cystic fibrosis locus and polymorphic DNA markers in 14 families. |
124. |
Horn SD et al. (1986) Misclassification problems in diagnosis-related groups. Cystic fibrosis as an example. |
125. |
Duncan AM et al. (1988) In situ hybridization of two cloned chromosome 7 sequences tightly linked to the cystic fibrosis locus. |
126. |
Searle AG et al. (1987) Chromosome maps of man and mouse, III. |
127. |
Welsh MJ et al. (1987) Cystic fibrosis. |
128. |
Gaskin KJ et al. (1988) Liver disease and common-bile-duct stenosis in cystic fibrosis. |
129. |
Jorde LB et al. (1988) A test of the heterozygote-advantage hypothesis in cystic fibrosis carriers. |
130. |
Katz SM et al. (1988) Microscopic nephrocalcinosis in cystic fibrosis. |
131. |
Baxter PS et al. (1988) Accounting for cystic fibrosis. |
132. |
Strain L et al. (1988) Use of linkage disequilibrium data in prenatal diagnosis of cystic fibrosis. |
133. |
Farrall M et al. (1986) Further data supporting linkage between cystic fibrosis and the met oncogene and haplotype analysis with met and pJ3.11. |
134. |
Tsui LC et al. (1986) Genetic analysis of cystic fibrosis using linked DNA markers. |
135. |
Vitale E et al. (1986) Homogeneity of cystic fibrosis in Italy. |
136. |
None (1987) Genetic counselling and antenatal diagnosis of cystic fibrosis. |
137. |
Ober C et al. (1987) Studies of cystic fibrosis in Hutterite families by using linked DNA probes. |
138. |
Boué A et al. (1986) Prenatal diagnosis in 200 pregnancies with a 1-in-4 risk of cystic fibrosis. |
139. |
Lander ES et al. (1986) Consanguinity and heterogeneity: cystic fibrosis need not be homogeneous in Italy. |
140. |
Romeo G et al. (1986) Homogeneity vs. heterogeneity of cystic fibrosis in Italy. |
141. |
Klinger K et al. (1986) Genetic homogeneity of cystic fibrosis. |
142. |
Widdicombe JH et al. (1985) Cystic fibrosis decreases the apical membrane chloride permeability of monolayers cultured from cells of tracheal epithelium. |
143. |
White R et al. () A closely linked genetic marker for cystic fibrosis. |
144. |
Wainwright B et al. (1986) Linkage between the cystic fibrosis locus and markers on chromosome 7q. |
145. |
Scambler PJ et al. (1986) Isolation of a further anonymous informative DNA sequence from chromosome seven closely linked to cystic fibrosis. |
146. |
Romeo G et al. (1985) Incidence in Italy, genetic heterogeneity, and segregation analysis of cystic fibrosis. |
147. |
Cattanach BM et al. () Differential activity of maternally and paternally derived chromosome regions in mice. |
148. |
Danes BS et al. (1968) A genetic cell marker in cystic fibrosis of the pancreas. |
149. |
Smith DW et al. (1968) Possible localisation of the gene for cystic fibrosis of the pancreas to the short arm of chromosome 5. |
150. |
Danes BS et al. (1968) Localisation of the cystic-fibrosis gene. |
151. |
Danes BS et al. (1969) Cystic fibrosis: an improved method for studying white blood-cells in culture. |
152. |
Danes BS et al. (1969) Cystic fibrosis: distribution of mucopolysaccharides in fibroblast cultures. |
153. |
Danes BS et al. (1969) Cystic fibrosis of the pancreas. A study in cell culture. |
154. |
Rao GJ et al. (1972) Deficiency of kallikrein activity in plasma of patients with cystic fibrosis. |
155. |
Rao GJ et al. (1974) Arginine esterase in cystic fibrosis of the pancreas. |
156. |
Di Sant'Agnese PA et al. (1967) Pathogenesis and physiopathology of cystic fibrosis of the pancreas. Fibrocystic disease of the pancreas (Mucoviscidosis). |
157. |
None (1970) Cystic fibrosis in adults. |
158. |
Oppenheimer EH et al. (1969) Observations on cystic fibrosis of the pancreas. V. Developmental changes in the male genital system. |
159. |
Oppenheimer EH et al. (1970) Observations on cystic fibrosis of the pancreas. VI. The uterine cervix. |
160. |
Oppenheimer EA et al. (1970) Cervical mucus in cystic fibrosis: a possible cause of infertility. |
161. |
Wright SW et al. (1968) Genetic studies on cystic fibrosis in Hawaii. |
162. |
Harris RL et al. (1968) Cystic fibrosis in the American Indian. |
163. |
Mangos JA et al. (1968) Studies on the mechanism of inhibition of sodium transport in cystic fibrosis of the pancreas. |
164. |
Blanck C et al. (1965) Mucoviscidosis and intestinal atresia. A study of four cases in the same family. |
165. |
Honeyman MS et al. (1965) Cystic fibrosis of the pancreas: an estimate of the incidence. |
166. |
Spock A et al. (1967) Abnormal serum factor in patients with cystic fibrosis of the pancreas. |
167. |
Manson JC et al. (1980) Development of a quantitative immunoassay for the cystic fibrosis gene. |
168. |
Stern RC et al. (1982) Obstructive azoospermia as a diagnostic criterion for the cystic fibrosis syndrome. |
169. |
Katznelson D et al. (1983) Detection of cystic-fibrosis genotypes. |
170. |
Edwards JH et al. (1984) Locus for cystic fibrosis. |
171. |
Cavenee W et al. (1984) Isolation and regional localization of DNA segments revealing polymorphic loci from human chromosome 13. |
172. |
Danks DM et al. (1983) Mutations at more than one locus may be involved in cystic fibrosis--evidence based on first-cousin data and direct counting of cases. |
173. |
None (1983) Cystic fibrosis in the Ohio Amish: gene frequency and founder effect. |
174. |
Baylin SB et al. (1980) Age-related abnormalities of circulating polyamines and diamine oxidase activity in cystic fibrosis heterozygotes and homozygotes. |
175. |
None (1983) Chloride impermeability in cystic fibrosis. |
176. |
Knowles M et al. (1983) Relative ion permeability of normal and cystic fibrosis nasal epithelium. |
177. |
Shapiro BL et al. (1982) Calcium and age in fibroblasts from control subjects and patients with cystic fibrosis. |
178. |
Brock DJ et al. (1982) Controlled trial of serum isoelectric focusing in the detection of the cystic fibrosis gene. |
179. |
Bullock S et al. (1982) Quantitative immunoassays for diagnosis and carrier detection in cystic fibrosis. |
180. |
Sing CF et al. (1982) Phenotypic heterogeneity in cystic fibrosis. |
181. |
Sanguinetti-Briceno NR et al. (1982) NADH dehydrogenase in cystic fibrosis. |
182. |
Shapiro BL et al. (1982) Mitochondrial NADH dehydrogenase in cystic fibrosis: enzyme kinetics in cultured fibroblasts. |
183. |
None (1980) A new genetic concept: uniparental disomy and its potential effect, isodisomy. |
184. |
Allan JL et al. (1981) Familial occurrence of meconium ileus. |
185. |
Breslow JL et al. (1981) Distinguishing homozygous and heterozygous cystic fibrosis fibroblasts from normal cells by differences in sodium transport. |
186. |
Mayo BJ et al. (1980) Somatic cell genetic studies of the cystic fibrosis mucociliary inhibitor. |
187. |
Gabriel SE et al. (1994) Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model. |
188. |
Crystal RG et al. (1994) Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. |
189. |
Zhou L et al. (1994) Correction of lethal intestinal defect in a mouse model of cystic fibrosis by human CFTR. |
190. |
Tebbutt SJ et al. (1995) Molecular analysis of the ovine cystic fibrosis transmembrane conductance regulator gene. |
191. |
Knowles MR et al. (1995) A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. |
192. |
Colledge WH et al. (1995) Generation and characterization of a delta F508 cystic fibrosis mouse model. |
193. |
Kerem E et al. (1995) Highly variable incidence of cystic fibrosis and different mutation distribution among different Jewish ethnic groups in Israel. |
194. |
Kubesch P et al. (1993) Genetic determinants of airways' colonisation with Pseudomonas aeruginosa in cystic fibrosis. |
195. |
Sheppard DN et al. (1993) Mutations in CFTR associated with mild-disease-form Cl- channels with altered pore properties. |
196. |
Hyde SC et al. (1993) Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy. |
197. |
Yang Y et al. (1993) An approach for treating the hepatobiliary disease of cystic fibrosis by somatic gene transfer. |
198. |
Yang Y et al. (1993) Molecular basis of defective anion transport in L cells expressing recombinant forms of CFTR. |
199. |
None (1995) Resolving DNA mutations. |
200. |
Neglia JP et al. (1995) The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group. |
201. |
Smyth RL et al. (1994) Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes. |
202. |
Dorin JR et al. (1994) Long-term survival of the exon 10 insertional cystic fibrosis mutant mouse is a consequence of low level residual wild-type Cftr gene expression. |
203. |
None (1994) Carrier risk calculations for recessive diseases when not all the mutant alleles are detectable. |
204. |
None (1993) Correlation between genotype and phenotype in patients with cystic fibrosis. The Cystic Fibrosis Genotype-Phenotype Consortium. |
205. |
Borgo G et al. (1993) Phenotypic intrafamilial heterogeneity in cystic fibrosis. |
206. |
Pier GB et al. (1996) Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. |
207. |
Rozmahel R et al. (1996) Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. |
208. |
Campbell KH et al. (1996) Sheep cloned by nuclear transfer from a cultured cell line. |
209. |
None (1996) Fibrosing colonopathy in cystic fibrosis. |
210. |
None (1995) Gene therapy for cystic fibrosis: challenges and future directions. |
211. |
Johannesson M et al. (1997) Delayed puberty in girls with cystic fibrosis despite good clinical status. |
212. |
de Vries HG et al. (1997) Prevalence of delta F508 cystic fibrosis carriers in The Netherlands: logistic regression on sex, age, region of residence and number of offspring. |
213. |
None (1997) The diagnosis of cystic fibrosis. |
214. |
Wilmut I et al. (1997) Viable offspring derived from fetal and adult mammalian cells. |
215. |
FitzSimmons SC et al. (1997) High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. |
216. |
Macek M et al. (1997) Identification of common cystic fibrosis mutations in African-Americans with cystic fibrosis increases the detection rate to 75%. |
217. |
Manson AL et al. (1997) Complementation of null CF mice with a human CFTR YAC transgene. |
218. |
Dankert-Roelse JE et al. (1997) Screening for cystic fibrosis--time to change our position? |
219. |
None (1997) Towards an ovine model of cystic fibrosis. |
220. |
Farrell PM et al. (1997) Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. |
221. |
Kent G et al. (1997) Lung disease in mice with cystic fibrosis. |
222. |
Collins A et al. (1998) Mapping a disease locus by allelic association. |
223. |
Brock DJ et al. (1998) The incidence of cystic fibrosis in Scotland calculated from heterozygote frequencies. |
224. |
Pier GB et al. (1998) Salmonella typhi uses CFTR to enter intestinal epithelial cells. |
225. |
Dörk T et al. (1998) Evidence for a common ethnic origin of cystic fibrosis mutation 3120+1G-->A in diverse populations. |
226. |
Muller F et al. (1998) Cystic fibrosis screening: a fetus with hyperechogenic bowel may be the index case. |
227. |
Matsui H et al. (1998) Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. |
228. |
Padoa C et al. (1999) Cystic fibrosis carrier frequencies in populations of African origin. |
229. |
None (1999) Status of gene therapy for cystic fibrosis lung disease. |
230. |
Hodge SE et al. (1999) Calculating posterior cystic fibrosis risk with echogenic bowel and one characterized cystic fibrosis mutation: avoiding pitfalls in the risk calculations. |
231. |
Ernst RK et al. (1999) Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. |
232. |
Reddy MM et al. (1999) Activation of the epithelial Na+ channel (ENaC) requires CFTR Cl- channel function. |
233. |
Restrepo CM et al. (2000) CFTR mutations in three Latin American countries. |
234. |
Wang J et al. (2000) A novel mutation in the CFTR gene correlates with severe clinical phenotype in seven Hispanic patients. |
235. |
Kabra M et al. (2000) Is the spectrum of mutations in Indian patients with cystic fibrosis different? |
236. |
Boyne J et al. (2000) Many deltaF508 heterozygote neonates with transient hypertrypsinaemia have a second, mild CFTR mutation. |
239. |
Castellani C et al. (2001) Analysis of the entire coding region of the cystic fibrosis transmembrane regulator gene in neonatal hypertrypsinaemia with normal sweat test. |
240. |
Tarran R et al. (2001) The CF salt controversy: in vivo observations and therapeutic approaches. |
241. |
Mateu E et al. (2002) Can a place of origin of the main cystic fibrosis mutations be identified? |
242. |
Scotet V et al. (2002) Prenatal detection of cystic fibrosis by ultrasonography: a retrospective study of more than 346 000 pregnancies. |
243. |
Groman JD et al. (2002) Variant cystic fibrosis phenotypes in the absence of CFTR mutations. |
244. |
Scotet V et al. (2002) Spatial and temporal distribution of cystic fibrosis and of its mutations in Brittany, France: a retrospective study from 1960. |
245. |
Meyer P et al. (2002) Analysis of the two common alpha-1-antitrypsin deficiency alleles PiMS and PiMZ as modifiers of Pseudomonas aeruginosa susceptibility in cystic fibrosis. |
246. |
Mekus F et al. (2003) Genes in the vicinity of CFTR modulate the cystic fibrosis phenotype in highly concordant or discordant F508del homozygous sib pairs. |
247. |
Kulczycki LL et al. (2003) A clinical perspective of cystic fibrosis and new genetic findings: relationship of CFTR mutations to genotype-phenotype manifestations. |
248. |
Coleman FT et al. (2003) Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection. |
249. |
Scotet V et al. (2003) Impact of public health strategies on the birth prevalence of cystic fibrosis in Brittany, France. |
250. |
None (1961) Fibrocystic disease of the pancreas: a comment. |
251. |
None (1960) Familial incidence of fibrocystic disease of the pancreas. |
252. |
Freedman SD et al. (2004) Association of cystic fibrosis with abnormalities in fatty acid metabolism. |
253. |
Mall M et al. (2004) Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice. |
254. |
Egan ME et al. (2004) Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. |
255. |
Quint A et al. (2005) Mutation spectrum in Jewish cystic fibrosis patients in Israel: implication to carrier screening. |
256. |
Nam MH et al. (2005) Variations of the CFTR gene in the Hanoi-Vietnamese. |
257. |
van de Vosse E et al. (2005) Susceptibility to typhoid fever is associated with a polymorphism in the cystic fibrosis transmembrane conductance regulator (CFTR). |
258. |
Drumm ML et al. (2005) Genetic modifiers of lung disease in cystic fibrosis. |
259. |
Stanke F et al. (2006) The TNFalpha receptor TNFRSF1A and genes encoding the amiloride-sensitive sodium channel ENaC as modulators in cystic fibrosis. |
260. |
Hardin DS et al. (2006) Growth hormone treatment improves growth and clinical status in prepubertal children with cystic fibrosis: results of a multicenter randomized controlled trial. |
261. |
Steinberg AG et al. (1960) On the Incidence of Cystic Fibrosis of the Pancreas. |
262. |
LOWE CU et al. (1949) Fibrosis of the pancreas in infants and children; a statistical study of clinical and hereditary features. |
263. |
Bremer LA et al. (2008) Interaction between a novel TGFB1 haplotype and CFTR genotype is associated with improved lung function in cystic fibrosis. |
264. |
Kravchenko VV et al. (2008) Modulation of gene expression via disruption of NF-kappaB signaling by a bacterial small molecule. |
265. |
Dequeker E et al. (2009) Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders--updated European recommendations. |
266. |
Rogers CS et al. (2008) Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. |
267. |
Gu Y et al. (2009) Identification of IFRD1 as a modifier gene for cystic fibrosis lung disease. |
268. |
O'Sullivan BP et al. (2009) Cystic fibrosis. |
269. |
Bartlett JR et al. (2009) Genetic modifiers of liver disease in cystic fibrosis. |
270. |
Harmon GS et al. (2010) Pharmacological correction of a defect in PPAR-gamma signaling ameliorates disease severity in Cftr-deficient mice. |
271. |
Chen JH et al. (2010) Loss of anion transport without increased sodium absorption characterizes newborn porcine cystic fibrosis airway epithelia. |
272. |
de Becdelièvre A et al. (2011) Comprehensive description of CFTR genotypes and ultrasound patterns in 694 cases of fetal bowel anomalies: a revised strategy. |
273. |
None (2012) Drug bests cystic-fibrosis mutation. |
274. |
Feuchtbaum L et al. (2012) Birth prevalence of disorders detectable through newborn screening by race/ethnicity. |
275. |
Emond MJ et al. (2012) Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis. |
276. |
Hoegger MJ et al. (2014) Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis. |
277. |
Wainwright CE et al. (2015) Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR. |
278. |
El-Harith EA et al. (1998) PCR-based analysis of cystic fibrosis mutations specific for Saudi patients. |
279. |
Rowe SM et al. (2017) Tezacaftor-Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis. |
280. |
Taylor-Cousar JL et al. (2017) Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del. |
281. |
Muraglia KA et al. (2019) Small-molecule ion channels increase host defences in cystic fibrosis airway epithelia. |